An essential resource for a bioanalyst!
The Bioanalysis and Bioanalysis Zone editorial teams are delighted to bring you a new Edition of The Bioanalysis Glossary, which continues to be regarded as an essential resource for everyone who works in bioanalysis or adjacent fields. A total of 15 leading experts in the bioanalytical field have been working closely with our editorial teams to provide a comprehensive update to the new edition of our glossary, reflecting the growing field of bioanalysis.
This guide is intended to be of great benefit to individuals who are new to the field or working with bioanalytical laboratories for the first time. Additionally, this glossary serves as a valuable reference for experienced bioanalysts who are working on research papers, reports or presentations. Since its creation, the Bioanalysis Glossary’s primary objective has been to facilitate the standardization of terminology used within the bioanalytical community, within and between companies, universities and individuals. In this increasingly globalized field, it has become necessary for scientists to speak the same bioanalytical language.
Key Features
- Lists terms, definitions and equations directly associated with the field of bioanalysis;
- Describes closely related techniques, technologies and applications of bioanalysis, which are important or useful for bioanalysts to understand.
- It covers (Bio)analytical techniques and equipment; Pharmacokinetics; Clinical trials; Metabolomics; Antidoping testing; Therapeutic drug monitoring; Regulatory and validation terminology; Drug development; and Statistical terminology.
Table of Contents:
Glossary Information. Sponsors. Preface. Scope. Disclaimer and Copyright information. List of Contributors. Taylor and Francis Editorial Department. Terms and Definitions. Index. Company profiles. Author guidelines
About the Author :
The Glossary Editorial Panel is drawn from the leading forces in bioanalysis:
Chaudhary A, Merck & Co., Inc., USA
Gopallawa I, AstraZeneca, USA
Gorovits B, Regeneron, USA
Hill H, ResolvPharma Consultancy Ltd, UK
Hodsdon M, Eli Lilly & Co., USA
Jones B, Crinetics Pharmaceuticals, USA
Li F, Biollege Bioanalytical Consulting, USA
MacNeill R, Bristol Myers Squibb, USA
Patel S, Johnson & Johnson, USA
Ramanathan R, QPS Holdings, LLC, USA
Spooner N, Spooner Bioanalytical Solutions, UK
Staack R, Roche Diagnostics GmbH, Germany
Vrentas C, Boston Biomarkers, USA
Wang L, Regeneron Pharmaceuticals Inc., USA
Zheng N, Bristol Myers Squibb, USA
